Axel Niendorf

Papers

Total Citations

H-Index

About

Axel Niendorf is a pioneering researcher in personalized oncology, with a primary focus on sensor-based screening technologies for cancer chemotherapy. His most cited work, "Sensor-based cell and tissue screening for personalized cancer chemotherapy" (2012), has garnered 24 citations and represents a significant contribution to the field of precision medicine. In this study, Niendorf developed innovative biosensor platforms that enable real-time, patient-specific assessment of tumor cell and tissue responses to chemotherapeutic agents. This approach allows for the rapid identification of the most effective drug regimens for individual patients, moving beyond traditional one-size-fits-all chemotherapy protocols. By integrating microfluidic systems with cellular impedance sensing, his research bridges the gap between laboratory diagnostics and clinical application, offering a non-invasive method to optimize treatment efficacy while minimizing toxic side effects. Niendorf's work has been instrumental in advancing the concept of functional drug sensitivity testing, providing a tangible pathway toward truly personalized cancer care. His contributions continue to influence the development of next-generation diagnostic tools, making him a key figure in the intersection of biomedical engineering and oncology.